Skip to main content
. 2020 Mar 30;64(4):412–417. doi: 10.20945/2359-3997000000228

Table 2. Correlation between the questionnaires’ results and the metabolic characteristics of the T1D patients (n = 66).

Questionnaires PSQI ESE BQ

Result > 5 (n = 30) ≤ 5 (n = 36) ≥ 10 (n = 22) < 10 (n = 44) High risk (n = 3) Low risk (n = 63)
BMI (kg/m2) 22.8 (21.6-25.0) 23.1 (21.7-26.6) 22.8 (21.8-24.6) 23.1 (21.5-25.4) 23.4 (22.5-24.2) 22.9 (21.6-25.4)
eGDR (mg.kg-1.min-1) 9.0 (8.1-9.6) 9.1 (6.3-10.4) 9.1 (7.3-9.7) 9.0 (8.1-10.2) 6.0 (5.0-6.9)c 9.1 (8.0-10.2)
HDL-c (mg/dL) 58.0 (51.0-69.0) 57.5 (46.0-66.0) 58.0 (51.0-66.0) 57.5 (46.5-69.5) 53.0 (47.5-63.5) 58.0 (49.0-67.5)
LDL-c (mg/dL) 103.0 (90.0-117.0)a 81.0 (72.0-95.0) 92.0 (75.5-107.5) 91.0 (76.0-111.0) 89.0 (82.0-96.0) 91.5 (75.5-112.0)
TC (mg/dL) 178.0 (166.0-206.0)b 159.5 (139.5-181.5) 170.5 (150.0-185.0) 168.0 (150.5-202.0) 176.0 (153.5-181.0) 168.0 (150.5-196.5)
TG (mg/dL) 89.0 (63.0-101.0) 67.5 (44.0-99.0) 64.0 (40.5-95.0) 86.5 (58.0-101.0) 72.0 (67.5-110.5) 80.0 (51.5-101.0)

Data presented as median (interquartile range). BMI: body mass index; eGDR: estimated glucose disposal ratio; TC: total cholesterol; TG: triglycerides; U: units; PSQI-BR: Pittsburgh Sleep Quality Index; ESE: Epworth Sleepiness Scale; BQ: Berlin Questionnaire; EDS: Excessive Diurnal Sleepiness; OSAS: Obstructive Sleep Apnea Syndrome. a p < .003; b p < .009; c p < .03.